Biohaven Ltd.
BHVN
$15.61
$0.936.34%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 38.03% | -23.49% | -29.07% | -56.28% | -253.94% |
| Total Depreciation and Amortization | 1.23% | 55.33% | 29.94% | 29.65% | 6.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -94.42% | 17.81% | -46.44% | -201.19% | 6,182.28% |
| Change in Net Operating Assets | 179.62% | -117.04% | 31.00% | 637.76% | -156.35% |
| Cash from Operations | -0.08% | -60.88% | -48.63% | -49.00% | -277.98% |
| Capital Expenditure | 92.10% | -4.77% | 89.57% | 51.04% | -395.63% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 83.81% | 385.15% | -2,444.34% | -255.17% | -223.09% |
| Cash from Investing | 84.13% | 384.50% | -2,140.06% | -259.52% | -228.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.66% | -83.25% | 14.06% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -623.95% | -- | -269.91% | 110.12% | 101.19% |
| Cash from Financing | -22.20% | -89.22% | 11.26% | 302.68% | 1,678.85% |
| Foreign Exchange rate Adjustments | -471.43% | 483.33% | 128.39% | 100.00% | 95.68% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 19.72% | 100.23% | -88.49% | -103.13% | 387.56% |